CHRO   $0.6955  -9.62% Market Closed After Close 0.7395 6.33%

Chromocell Therapeutics Corp
Total Cash 2.41M
totalCashPerShare 0.417
EBITDA
Total Debt 1.59M
quickRatio 0.863
currentRatio 0.934
Total Revenue
debtToEquity
Revenue/Share
ROA -4.12802
ROE
grossProfits
freeCashflow -6.49M
operatingCashflow -5.56M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 4.32M
forwardPE -0.80999994
floatShares 1.33M
sharesOutstanding 5.77M
sharesShort 31.67K
sharesShortPriorMonth 21.83K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.81%
heldPercentInstitutions 0.09%
Short Ratio help_outline 0.24%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -0.031
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -9.79M
trailingEps -1.68%
forwardEps -1.10%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.55
institutionsCount 7
lastUpdated Oct. 17, 2024, 4:23 p.m.